Saurashtra News

Chondrosarcoma Market Size in the 7MM is projected to grow at a 16% CAGR over the forecast period of 2026-2036 | DelveInsight

Chondrosarcoma Market Size in the 7MM is projected to grow at a 16% CAGR over the forecast period of 2026-2036 | DelveInsight

The Key Chondrosarcoma Companies in the market include – Servier, Inhibrx, and others. (Albany, US), October 28, 2026 – DelveInsight’s ‘Chondrosarcoma Market Insights, Epidemiology and Market Forecast – 2036’ report

Read Full Article

Hemophilia B Market Size in the 7MM is projected to grow at a CAGR of 8.4% over the forecast period of 2026-2036 | DelveInsight

The Key Hemophilia B Companies in the market include – Centessa Pharmaceuticals, Sanofi (Genzyme), Alnylam Pharmaceuticals, Pfizer, Spark Therapeutics, Be Biopharma, Equilibra Bioscience, Regeneron Pharmaceuticals, Intellia Therapeutics, Novo Nordisk, and

Read Full Article

Metastatic HER2 Positive Breast Cancer Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2026-2036 | DelveInsight

The Key Metastatic HER2 Positive Breast Cancer Companies in the market include – Byondis, Roche, Pfizer, Ambrx, Bolt Biotherapeutics, BioInvent International AB, Klus Pharma, DualityBio, Artiva Biotherapeutics, Vaccinex, Suzhou Zanrong

Read Full Article

Influenza A Market Size in the 7MM is projected to reach ~USD 10,000 million by 2036, growing at a CAGR of 7.9% during 2026-2036 | DelveInsight

The Key Influenza A Companies in the market include – Roche, BioCryst Pharmaceuticals, Seqirus, Moderna, Merck, GlaxoSmithKline, Cocrystal Pharma, and others. (Albany, US), October 28, 2026 – DelveInsight’s ‘Influenza A

Read Full Article

Diabetic Retinopathy Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Diabetic Retinopathy clinical trial analysis report delivers important insights into ongoing research on 55+ pipeline drugs, clinical strategies, upcoming

Read Full Article

Dry Eye Disease Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Dry Eye Disease clinical trial analysis report delivers important insights into ongoing research on 60+ pipeline drugs, clinical strategies,

Read Full Article

Encephalopathy Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Encephalopathy clinical trial analysis report delivers important insights into ongoing research on 55+ pipeline drugs, clinical strategies, upcoming therapeutics,

Read Full Article

Cannabinoid Agonist Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Cannabinoid Agonist clinical trial analysis report delivers important insights into ongoing research on 22+ pipeline drugs, clinical strategies, upcoming

Read Full Article

Charcot Marie Tooth Disease Clinical Trial Pipeline Gains Momentum: 13+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Charcot Marie Tooth Disease clinical trial analysis report delivers important insights into ongoing research on 15+ pipeline drugs, clinical

Read Full Article

Anaplastic Lymphoma Kinase-positive Non-Small Cell Lung Cancer Market is Projected to Grow by 2036 Owing to the Advancement of Novel Targeted Therapies | DelveInsight

The market dynamics for Anaplastic Lymphoma Kinase-positive Non-Small Cell Lung Cancer (ALK-positive NSCLC) are witnessing steady growth driven by increasing

Read Full Article